Education
About Us
Working with TipRanks
Follow Us
Bio-Techne (TECH)
NASDAQ:TECH
Total Valuation
Bio-Techne has a market cap or net worth of $8.95B. The enterprise value is $8.95B.
Market Cap$8.95B
Enterprise Value$8.95B
Share Statistics
Bio-Techne has 155,812,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding155,812,700
Owned by Insiders0.28%
Owned by Institutions32.64%
Financial Efficiency
Bio-Techne’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.16%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.16%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee393.43K
Profits Per Employee23.68K
Employee Count3,100
Asset Turnover0.48
Inventory Turnover2.27
Valuation Ratios
The current PE Ratio of Bio-Techne is 117.4. Bio-Techne’s PEG ratio is -1.97.
PE Ratio117.4
PS Ratio6.64
PB Ratio4.22
Price to Fair Value4.22
Price to FCF31.59
Price to Operating Cash Flow39.92
PEG Ratio-1.97
Income Statement
In the last 12 months, Bio-Techne had revenue of 1.22B and earned 73.40M in profits. Earnings per share was 0.47.
Revenue1.22B
Gross Profit790.27M
Operating Income102.25M
Pretax Income98.46M
Net Income73.40M
EBITDA216.88M
Earnings Per Share (EPS)0.47
Cash Flow
In the last 12 months, operating cash flow was 251.25M and capital expenditures -27.20M, giving a free cash flow of 224.06M billion.
Operating Cash Flow251.25M
Free Cash Flow224.06M
Free Cash Flow per Share1.44
Dividends & Yields
Bio-Techne pays an annual dividend of $0.08, resulting in a dividend yield of 0.56%
Dividend Per Share$0.08
Dividend Yield0.56%
Payout Ratio16.58%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change-19.82%
50-Day Moving Average61.07
200-Day Moving Average55.24
Relative Strength Index (RSI)38.14
Average Volume (3m)1.92M
Important Dates
Bio-Techne upcoming earnings date is Feb 3, 2026, Before Open (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateFeb 3, 2026
Ex-Dividend Date―
Financial Position
Bio-Techne as a current ratio of 3.46, with Debt / Equity ratio of 19.13%
Current Ratio3.46
Quick Ratio2.38
Debt to Market Cap0.04
Net Debt to EBITDA1.30
Interest Coverage Ratio12.02
Taxes
In the past 12 months, Bio-Techne has paid 25.06M in taxes.
Income Tax25.06M
Effective Tax Rate0.25
Enterprise Valuation
Bio-Techne EV to EBITDA ratio is 38.67, with an EV/FCF ratio of 32.69.
EV to Sales6.88
EV to EBITDA38.67
EV to Free Cash Flow32.69
EV to Operating Cash Flow29.16
Balance Sheet
Bio-Techne has $144.96M in cash and marketable securities with $394.47M in debt, giving a net cash position of -$249.51M billion.
Cash & Marketable Securities$144.96M
Total Debt$394.47M
Net Cash-$249.51M
Net Cash Per Share-$1.60
Tangible Book Value Per Share$3.63
Margins
Gross margin is 65.37%, with operating margin of 8.38%, and net profit margin of 6.02%.
Gross Margin65.37%
Operating Margin8.38%
Pretax Margin8.07%
Net Profit Margin6.02%
EBITDA Margin17.78%
EBIT Margin8.77%
Analyst Forecast
The average price target for Bio-Techne is $67.38, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$67.38
Price Target Upside18.23% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast3.85%
EPS Growth Forecast-48.17%